Follow
Stewart Wolmark
Stewart Wolmark
Stewart Wolmark is chairman of the National Surgical Adjuvant Breast Project and a professor of
Verified email at pcc.edu
Title
Cited by
Cited by
Year
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
B Fisher, S Anderson, J Bryant, RG Margolese, M Deutsch, ER Fisher, ...
New England Journal of Medicine 347 (16), 1233-1241, 2002
78972002
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, ...
New England Journal of Medicine 351 (27), 2817-2826, 2004
71482004
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond, EA Perez, J Bryant, VJ Suman, CE Geyer Jr, NE Davidson, ...
New England journal of medicine 353 (16), 1673-1684, 2005
70002005
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
B Fisher, JP Costantino, DL Wickerham, CK Redmond, M Kavanah, ...
JNCI: Journal of the National Cancer Institute 90 (18), 1371-1388, 1998
67821998
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
61412005
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
P Cortazar, L Zhang, M Untch, K Mehta, JP Costantino, N Wolmark, ...
The Lancet 384 (9938), 164-172, 2014
42392014
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer
S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, ...
Journal of clinical oncology 24 (23), 3726-3734, 2006
31032006
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, ER Fisher, ...
Journal of clinical oncology 16 (8), 2672-2685, 1998
27851998
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
B Fisher, M Bauer, R Margolese, R Poisson, Y Pilch, C Redmond, ...
New England Journal of Medicine 312 (11), 665-673, 1985
23351985
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, RG Margolese, ...
Journal of clinical oncology 15 (7), 2483-2493, 1997
23121997
Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
B Fisher, C Redmond, R Poisson, R Margolese, N Wolmark, L Wickerham, ...
New England Journal of Medicine 320 (13), 822-828, 1989
22821989
Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27
P Rastogi, SJ Anderson, HD Bear, CE Geyer, MS Kahlenberg, ...
Journal of Clinical Oncology 26 (5), 778-785, 2008
21652008
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21551998
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from …
DN Krag, SJ Anderson, TB Julian, AM Brown, SP Harlow, JP Costantino, ...
The lancet oncology 11 (10), 927-933, 2010
21392010
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of …
B Fisher, S Anderson, CK Redmond, N Wolmark, DL Wickerham, ...
New England Journal of Medicine 333 (22), 1456-1461, 1995
21091995
Trastuzumab emtansine for residual invasive HER2-positive breast cancer
G Von Minckwitz, CS Huang, MS Mano, S Loibl, EP Mamounas, M Untch, ...
New England Journal of Medicine 380 (7), 617-628, 2019
20912019
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial
VG Vogel, JP Costantino, DL Wickerham, WM Cronin, RS Cecchini, ...
Jama 295 (23), 2727-2741, 2006
20912006
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
B Fisher, C Redmond, ER Fisher, M Bauer, N Wolmark, DL Wickerham, ...
New England Journal of Medicine 312 (11), 674-681, 1985
18841985
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor–positive tumors
B Fisher, J Costantino, C Redmond, R Poisson, D Bowman, J Couture, ...
New England Journal of Medicine 320 (8), 479-484, 1989
18471989
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation
B Fisher, JH Jeong, S Anderson, J Bryant, ER Fisher, N Wolmark
New England Journal of Medicine 347 (8), 567-575, 2002
17672002
The system can't perform the operation now. Try again later.
Articles 1–20